Category: Around the Industry

  • HPW Says ‘Industry Interference’ Stalled COP Decisions

    HPW Says ‘Industry Interference’ Stalled COP Decisions

    In its overview of the Eleventh Conference of the Parties (COP11), Health Policy Watch said that “industry interference remains the main issue preventing concrete steps toward more effective control of new tobacco products.” The article said that despite extensive debate, delegates failed to reach a consensus on issues such as plastic cigarette filters and disclosure requirements, opting instead for informal consultations, blaming outside forces that influenced delegates who pitched “competing drafts.”  

    “We know very well what works and what doesn’t,” Filippos Filippidis, Chair of the Tobacco Control Committee at the European Respiratory Society and Associate Professor at the School of Public Health at Imperial College London, was quoted in the article “The problem is that because of interference and the big money that is involved, some countries remain reluctant to apply some of these policies.”

    According to Health Policy Watch, delegates agreed to increase state funding for domestic tobacco control programs, consider more forward-looking measures such as generational bans on cigarettes, and approved calling on Parties to consider stronger legislative action to deal with criminal and civil liability related to tobacco control.

    However, Health Policy Watch said the “most controversial topic,” which did not get settled, concerned the way new products, such as electronic and heated tobacco and nicotine products, should be addressed, which leads into the “harm-reduction” argument that many anti-tobacco advocates believe is Big Tobacco propaganda. Industry representatives argue that the controversy and contention could be reduced via open discourse with all interested parties, and often criticize the WHO Framework Convention on Tobacco Control (FCTC) for working in secrecy and prohibiting open dialogue.

    Andrew Black, Acting Head of the Secretariat, said the unsolved discussion would be addressed at COP12 in Armenia in 2027, while Gan Quan, senior vice president of Tobacco Control at the New York City-based Vital Strategies, gave little hope that outside input would be welcomed.

    “We saw an unprecedented level of industry interference at this COP,” Quan said. “In terms of the composition of the delegations, it’s a bit out of control. The goal for future progress is to do a better job in keeping the industry out of that discussion.”

  • Malaysia to Study Effects of IQOS

    Malaysia to Study Effects of IQOS

    Malaysia’s Home Ministry recommended that the National Poison Center conduct a study on IQOS, Philip Morris’ heated tobacco product. Minister Datuk Seri Saifuddin Nasution Ismail said the health effects of the device are not yet known, but an initial study would help prepare the government for future legislation. Speaking at a seminar, he described the product as a “new innovation posing regulatory challenges.” He emphasized that laws on poisons and drug abuse must remain dynamic to address emerging substances.

    Saifuddin added that while the device’s marketing campaign advises non-smokers not to start and encourages smokers to quit or switch, the government must be proactive in assessing potential risks. He suggested that legal amendments could be drafted broadly to prevent loopholes.

  • Labstat Introduces New President

    Labstat Introduces New President

    Labstat Inc., a Certified Group company and the world’s largest independent nicotine testing laboratory, announced that it has appointed Scott LaNeve as its new president. LaNeve brings more than three decades of leadership experience across life sciences, diagnostics, and healthcare technology, having held senior roles at Abbott Laboratories, Roche Diagnostics, and Quest Diagnostics, as well as executive positions in national laboratory networks and technology firms.

    In a statement, LaNeve said he was honored to join Labstat, which operates laboratories in Canada, the U.S., and Europe specializing in nicotine, tobacco, and cannabis testing. He emphasized his commitment to advancing Labstat’s role in global tobacco harm reduction by delivering trusted testing and actionable, data-driven insights to clients. Certified Group CEO David Morgan welcomed the appointment, citing LaNeve’s strategic vision and operational expertise as key to reinforcing Labstat’s leadership worldwide.

  • PMI CEO to Present at Morgan Stanley Conference

    PMI CEO to Present at Morgan Stanley Conference

    Philip Morris International Inc. announced it will host a live webcast of a fireside chat session with CEO Jacek Olczak at the 2025 Morgan Stanley Global Consumer & Retail Conference on December 2, at approximately 10:15 a.m. ET. An archived copy of the webcast will be available for six months post-event. The webcast can be accessed here, or on mobile devices by downloading PMI’s free Investor Relations Mobile App at www.pmi.com/irapp.

  • Zimbabwe Opens $100M Tobacco Plant, Part of 2030’s $7B Goal

    Zimbabwe Opens $100M Tobacco Plant, Part of 2030’s $7B Goal

    Zimbabwean President Emmerson Mnangagwa inaugurated a $100 million tobacco processing plant in Harare last week, developed by agribusiness firm Cut Rag Processors (CRP). The facility can process 3,000 tons of tobacco monthly into cut rag and produce up to 60,000 master cases of cigarettes, equivalent to 600 million sticks. The investment is intended to strengthen Zimbabwe’s limited processing capacity, as the country’s 10 cigarette manufacturers currently produce 4.4 billion cigarettes annually but process only 10–15% of local tobacco. The Tobacco Industry and Marketing Board (TIMB) aims to raise this rate to 30% through private investment to capture more value in the export-oriented sector.

    The expansion supports the government’s target of generating $7 billion in tobacco sector revenues by 2030 under the Food Systems, Agriculture and Rural Transformation Strategy. Zimbabwe earned $1.4 billion from tobacco exports in 2024, with 94% from unprocessed leaf. Production continues to grow rapidly, with the 2025 harvest rising 53% to a record 354,000 tons, representing 92% growth since 2020. TIMB projects output could reach nearly 500,000 tons by 2030, but limited processing capacity remains a challenge.

  • Tobacco Imagery in Movies Increases 10%: Report

    Tobacco Imagery in Movies Increases 10%: Report

    The new report from the Truth Initiative found that more than half of 2024’s top films featured tobacco imagery, an increase of 10 percentage points from the previous year. The Tobacco in Films: 2024 report found that 51% of the top 152 box office films contained tobacco imagery, up from 41% in 2023, with a 43% surge in total tobacco incidents (2,858 in 2024 versus 1,989 in 2023). Among films rated appropriate for youth (G, PG, and PG-13), 34% included tobacco imagery.

    According to the report, studios outside of the Motion Picture Association (MPA) were responsible for the majority of tobacco depictions, with companies such as Amazon, A24, and other independent distributors driving the surge. In 2024, non-MPA studios released 69 films featuring tobacco use, compared with eight movies from MPA member studios. 

    The report builds on Truth Initiative’s longstanding While You Were Streaming report series, which has led efforts to raise awareness and drive action on the impact of tobacco depictions on screens.

  • Thailand Finding Rise of Narcotic-Laced Vapes

    Thailand Finding Rise of Narcotic-Laced Vapes

    Thailand’s Department of Medical Sciences (DMS) warned that e-cigarettes are increasingly being laced with etomidate, a short-acting anesthetic that poses serious risks to the brain, respiratory system, and other vital organs. Tests conducted between October 2024 and June 2025 found etomidate in 56 of 83 e-cigarette and equipment samples. The Thai Food and Drug Administration (FDA) classified etomidate as a Special Controlled Drug before elevating it to a Schedule 2 Psychotropic Substance on July 27, to enforce stricter importation and usage rules. Despite this, the anesthetic has been detected in e-cigarettes produced in Asia and in smuggled e-liquids entering Thailand.

    Reports indicate that etomidate is being mixed with or substituted for nicotine in modified e-cigarettes known as “Zombie Cigarettes” or “Pot K.” The DMS has developed a testing method to detect the substance, which will aid police in drug suppression efforts. Authorities have also found e-cigarettes laced with narcotics such as cocaine and fentanyl, raising concerns about increased fatality risks among users.

  • NYC, Vape Companies Settle Flavor Dispute

    NYC, Vape Companies Settle Flavor Dispute

    New York City reached a settlement with two e-cigarette wholesalers accused of distributing flavored vapes in violation of the city’s ban, according to Law 360. Under the agreement, EnviroMD Group and GT Imports will stop pushing these products within the five boroughs, facing $1,000 fines for any future violations. The move comes as part of a broader crackdown by the NYC Law Department, which has filed lawsuits against multiple distributors for illegally supplying disposable flavored e-cigarettes.

    This settlement is one piece of the city’s aggressive enforcement effort against flavored nicotine products. The administration has pursued both civil penalties and court orders to block sales and distribution, emphasizing its commitment to protecting youth from flavored vape devices.

  • Tabacalera USA Announces Executive Changes

    Tabacalera USA Announces Executive Changes

    Tabacalera USA recently announced several key leadership moves across its retail and distribution businesses, as first reported by Halfwheel. Brad Winstead, former CEO of JR Cigar, has been named CEO of Casa de Montecristo and Santa Clara, Inc., replacing Sherri Sieminski, who, according to Halfwheel, is no longer with the company. Nicolas Maslowski, previously JR Cigar’s e-commerce COO, now serves as CEO of JR Cigar.

    JR Cigar remains the company’s flagship retail brand, while Casa de Montecristo represents its higher-end physical store network, and Santa Clara, Inc. handles wholesale distribution to other retailers.

    Javier Estades, Tabacalera USA’s president and CEO, said the changes reflect the “success and versatility of these leaders” and reaffirm the company’s focus on delivering premium products, innovative programs, and strong service across its retail and trade operations.

  • NPR Article Explores the THR Debate

    NPR Article Explores the THR Debate

    A new article by Gabrielle Emanuel and Arundathi Nair for NPR—titled Can Vaping Help Wean People Off Cigarettes? Anti-Smoking Advocates are Sharply Split—explores the debate over e-cigarettes, heated tobacco, and nicotine pouches as the WHO Tobacco Control Treaty meeting in Geneva concludes. The story examines the clash between advocates of harm reduction, who see these products as less harmful alternatives for smokers, and WHO and public health experts, who warn of risks to youth and non-smokers and accuse the industry of promoting nicotine addiction.

    The article highlights perspectives from prominent figures like Dr. Derek Yach, founder of the Foundation for a Smoke-Free World, and Professor Mike Cummings, both supporting harm reduction strategies, alongside WHO officials who stress potential harms and the need for strict regulation. It also explores the historical context of tobacco industry tactics and the ongoing tensions between science, policy, and ideology.

    “We ought to get the evidence and weigh it and debate it — and help guide the policies based on evidence, not on ideology,” Cummings concludes.